Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,794 | 855 | 98.4% |
| Education | $167.75 | 11 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $149.88 | 2 | 0.6% |
| Debt forgiveness | $71.06 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,493 | 148 | $0 (2024) |
| Novo Nordisk Inc | $2,685 | 155 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,512 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,859 | 69 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,442 | 56 | $0 (2023) |
| Amarin Pharma Inc. | $1,188 | 42 | $0 (2022) |
| PFIZER INC. | $1,166 | 51 | $0 (2024) |
| Amgen Inc. | $1,059 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $768.86 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $727.40 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,598 | 83 | AstraZeneca Pharmaceuticals LP ($1,399) |
| 2023 | $2,779 | 77 | AstraZeneca Pharmaceuticals LP ($717.34) |
| 2022 | $2,515 | 78 | AstraZeneca Pharmaceuticals LP ($1,020) |
| 2021 | $1,938 | 94 | AstraZeneca Pharmaceuticals LP ($447.48) |
| 2020 | $2,447 | 131 | PFIZER INC. ($389.40) |
| 2019 | $3,711 | 139 | AstraZeneca Pharmaceuticals LP ($633.79) |
| 2018 | $4,302 | 137 | Janssen Pharmaceuticals, Inc ($759.41) |
| 2017 | $2,893 | 130 | SANOFI-AVENTIS U.S. LLC ($637.82) |
All Payment Transactions
869 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $114.37 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.76 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: DIABETES | ||||||
| 10/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: UROLOGY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $126.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $119.76 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: Endocrinology | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Respiratory | ||||||
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $124.88 | General |
| Category: UROLOGY | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $34.63 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: VACCINES | ||||||
| 07/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 239 | 379 | $58,603 | $32,172 |
| 2022 | 5 | 228 | 330 | $48,927 | $29,579 |
| 2021 | 10 | 299 | 444 | $60,360 | $37,843 |
| 2020 | 11 | 364 | 505 | $56,673 | $34,620 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 198 | $31,658 | $17,461 | 55.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $11,020 | $6,035 | 54.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $5,120 | $2,744 | 53.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 49 | $6,160 | $2,272 | 36.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 26 | $1,700 | $1,664 | 97.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 17 | $2,188 | $1,253 | 57.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $757.50 | $742.25 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 192 | $29,975 | $17,677 | 59.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 45 | 45 | $11,430 | $6,461 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 41 | $4,945 | $2,938 | 59.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 28 | $1,870 | $1,809 | 96.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 24 | $706.90 | $693.28 | 98.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 207 | $31,300 | $19,612 | 62.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 66 | $7,855 | $4,949 | 63.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 32 | 32 | $8,000 | $4,692 | 58.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 21 | $4,800 | $3,216 | 67.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 26 | 26 | $1,710 | $1,691 | 98.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,339 | $1,416 | 60.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 17 | 20 | $2,475 | $1,401 | 56.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 29 | 29 | $865.66 | $556.51 | 64.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 16 | 17 | $735.00 | $225.42 | 30.7% |
| 97026 | Application of low energy heat (infrared) to 1 or more areas | Office | 2021 | 12 | 15 | $280.01 | $82.60 | 29.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 179 | $23,790 | $14,413 | 60.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 35 | 35 | $8,100 | $4,501 | 55.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 62 | $6,135 | $3,552 | 57.9% |
About Dr. Daniel Jimenez, MD
Dr. Daniel Jimenez, MD is a Family Medicine healthcare provider based in Santa Ana, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255466801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Jimenez, MD has received a total of $24,183 in payments from pharmaceutical and medical device companies, with $3,598 received in 2024. These payments were reported across 869 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($23,794).
As a Medicare-enrolled provider, Jimenez has provided services to 1,130 Medicare beneficiaries, totaling 1,658 services with total Medicare billing of $134,214. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Santa Ana, CA
- Active Since 02/23/2007
- Last Updated 04/19/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255466801
Products in Payments
- FARXIGA (Drug) $2,964
- XARELTO (Drug) $1,948
- Vascepa (Drug) $1,188
- TRULICITY (Drug) $1,105
- Ozempic (Drug) $948.88
- BREZTRI (Drug) $827.18
- SOLIQUA (Drug) $732.05
- JARDIANCE (Drug) $659.55
- INVOKANA (Drug) $549.64
- AIRSUPRA (Drug) $529.63
- MOUNJARO (Drug) $518.89
- ENTRESTO (Drug) $487.82
- EVENITY (Biological) $480.62
- Victoza (Drug) $427.31
- Tresiba (Drug) $409.21
- CHANTIX (Drug) $396.06
- Prolia (Biological) $381.89
- MYRBETRIQ (Drug) $377.87
- Kerendia (Drug) $373.20
- SOLIQUA 100/33 (Biological) $245.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Santa Ana
Charles P Vega, Md, MD
Family Medicine — Payments: $126,760
Dr. Bruno Bucci, M.d, M.D
Family Medicine — Payments: $37,692
Dr. Mark Monroe, M.d, M.D
Family Medicine — Payments: $14,374
Dr. Quang Binh Nguyen, Md, MD
Family Medicine — Payments: $12,286
Fernando Martinez, M.d, M.D
Family Medicine — Payments: $11,979
Dr. Darrel Hopkins, D.o, D.O
Family Medicine — Payments: $6,529